Akira Kunimatsu MD, Presenter: Speakers Bureau, Terumo Corporation

Harushi Mori MD, Abstract Co-Author: Nothing to Disclose

Shiori Amemiya MD, Abstract Co-Author: Nothing to Disclose

Masaki Katsura MD, Abstract Co-Author: Nothing to Disclose

Natsuko Kunimatsu MD, Abstract Co-Author: Nothing to Disclose

Kuni Ohtomo MD, Abstract Co-Author: Research Grant, Bayer AG Research Grant, DAIICHI SANKYO Group

The purpose of this exhibit is: To review the current concept on genetic alterations of glioblastoma and relevant imaging biomarkers To understand MR imaging findings of glioblastoma with relation to tumor prognosis To discuss how imaging modalities should be used in pre-operative evaluation and post-treatment follow-up

Genetics and imaging genomics of glioblastoma Tumor biology of glioblastoma and relevant imaging findings Imaging findings and prognosis Imaging strategies to follow up the evolution pathways from low-grade astrocytoma to glioblastoma Evaluation of treatment response and its pitfalls Detection of tumor recurrence and discrimination from necrosis

http://abstract.rsna.org/uploads/2014/14003999/14003999_xq3j.pdf

Kunimatsu, A, Mori, H, Amemiya, S, Katsura, M, Kunimatsu, N, Ohtomo, K, Essentials of Glioblastoma: Current Clinical Issues and Imaging Challenges.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14003999.html